Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis

By sjmartinez • July 16, 2024

Volkmann ER, Denton CP, Kolb M, Wijsenbeek-Lourens MS, Emson C, Hudson K, Amatucci AJ, Distler O, Allanore Y, Khanna D. Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis. Eur Respir Rev. 2024 Jun 12;33(172):240015. doi: 10.1183/16000617.0015-2024. PMID: 39009409.

Tags: Publications, Rheumatology

CAR immunotherapy in autoimmune diseases: promises and challenges

Yu J, Yang Y, Gu Z, Shi M, La Cava A, Liu A. CAR immunotherapy in autoimmune diseases: promises and challenges. Front Immunol. 2024 Oct[...]

Informing estimates of probability of Clostridioides difficile infection for testing and treatment: expert consensus from a modified-Delphi procedure

Baghdadi JD, Wessel M, Dubberke ER, Lydecker A, Claeys KC, Alonso C, Coffey KC, Durkin M, Gonzales-Luna AJ, Guh AY, Kwon JH, Martin E, Mehrotra[...]

Tertiary Care Center Trends in Colonic Stent Placement over the Past Decade

Juakiem WY, Singh K, Ofosu A, Ramai D, Persaud A, Tabibian JH, Rodrigues-Pinto E, Girotra M, Barakat MT. Tertiary Care Center Trends in Colonic Stent[...]